Symbollon Pharmaceuticals, Inc. (OTC BB: SYMBA) today announced financial results for the year ended December 31, 2005. The Company reported a net loss of $(645,973), or $(0.09) per share, compared with a net loss of $(2,647,108), or $(0.53) per share, in the prior year.
